GRI Bio's total assets for Q1 2026 were $5.67M, a decrease of -1.12% from the previous quarter. GRI total liabilities were $2.35M for the fiscal quarter, a 37.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.